News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO
Harold J. Burstein/X
Jun 7, 2025, 12:23

Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO

Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared a post on X:

“After ASCO, so much to discuss about breast cancer! Which agents, when, for how long, in whom? Get all the answers at our renowned 2-day breast program with outstanding faculty from Dana-Farber Cancer Institute and Mass General Cancer Center. In-person and virtual options.”

Read further.

Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO

More posts featuring Harold J. Burstein.

ASCO Breast Cancer cancer Dana-Farber Cancer Institute Harold J. Burstein Mass General Cancer Center OncoDaily Oncology
Special Coverage
Blog
Jun 7, 2025, 14:53
Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25
Blog
Jun 7, 2025, 14:44
SPCC Will Host Webinar on Early Nutrition Screening and Intervention in Cancer Care
Insight
Jun 7, 2025, 14:38
Paolo Tarantino: Thanks to NSABP-B51, Countless Patients Will Be Spared the Toxicity of Nodal Irradiation
Blog
Jun 7, 2025, 14:12
Vinod Balachandran on Pancreatic Cancer and Its Prognosis - Memorial Sloan Kettering Cancer Center
Insight
Jun 7, 2025, 14:10
Childhood Cancer International Receives $50,000 Donation from MKA Group
Blog
Jun 7, 2025, 14:03
Nina Niu Sanford: The Simultaneous ASCO 2025 Presentation and Pubs Were Great
Blog
Jun 7, 2025, 13:44
Luis E. Raez: Florida CCRAB Meeting Focuses on New Florida Cancer Control Plan
Blog
Jun 7, 2025, 13:19
Caterina Sposetti: ASCO25 Was Filled With Science, Inspiration, and Meaningful Connections
Blog
Jun 7, 2025, 12:46
Alexandre Chan: Can a Team-based Approach Transform Cancer Survivorship Care?
Blog
Jun 7, 2025, 12:39
Drew Moghanaki: SAFRON II Was a "SABR in Lieu of Systemic Therapy" Study for Lung Metastases
Blog
Jun 7, 2025, 12:30
Adrelia Allen: ASCO25 Highlights - Meaningful Discussions on Clinical Trial Diversity
Blog
Jun 7, 2025, 12:23
Harold J. Burstein: So Much to Discuss About Breast Cancer After ASCO